| Hydrochlorothiazide/Valsartan |
Tablet |
|
|
Refer to USP |
|
|
2016/07/28 |
| Hydrochlorothizide/Triamterene |
Capsule |
|
|
Refer to USP |
|
|
2008/10/06 |
| Hydrocodone Bitartrate |
Capsule (Extended Release) |
I (Basket) |
100 |
0.05 M Phosphate Buffer, pH 6.8 |
500 |
1, 2, 4, 6, 8, 10 and 12 hours |
2015/05/28 |
| Hydrocodone Bitartrate |
Tablet (Extended Release) |
I (Basket-10 mesh) |
100 |
Simulated gastric fluid (SGF) without enzyme (pH 1.2) |
900 |
1, 2, 4, 8, 12, 16, 20 and 24 hours |
2016/04/14 |
| Hydrocodone Bitartrate/Ibuprofen |
Tablet |
II (Paddle) |
50 |
Phosphate Buffer, pH 7.2 |
900 |
5, 10, 15 and 30 |
2004/02/04 |
| Hydrocortisone |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Hydromorphone HCl |
Tablet (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Hydromorphone HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Hydroxychloroquine Sulfate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/04/16 |
| Hydroxyurea |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Hydroxyurea |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2022/07/07 |
| Hydroxyzine HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Hydroxyzine Pamoate |
Capsule |
|
|
Refer to USP |
|
|
2009/04/02 |
| Hydroxyzine Pamoate |
Suspension |
|
|
Develop a dissolution method |
|
|
2009/04/02 |
| Ibandronate Sodium |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Ibrexafungerp Citrate |
Tablet |
II (Paddle) |
50 |
0.1N HCl |
900 |
10, 15, 20, 30 and 45 |
2023/02/09 |
| Ibrutinib |
Capsule |
II (Paddle) |
75 |
3.0% w/v Polysorbate 20 in 50 mM Phosphate Buffer, pH 6.8 |
900 |
5, 10, 20, 30 and 45 |
2015/06/25 |
| Ibrutinib |
Suspension |
II (Paddle) |
25 |
0.05 M potassium phosphate buffer, pH 6.8, w/ 1.5% (w/v) Tween 20 |
900 |
5, 10, 15, 20, 30, 45 and 60 |
2025/09/08 |
| Ibrutinib (140 and 280 mg) |
Tablet |
II (Paddle) |
75 |
3.0% w/v Polysorbate 20 in 50 mM Phosphate Buffer, pH 6.8 |
900 |
10, 20, 30, 45 and 60 |
2020/04/02 |
| Ibrutinib (420 and 560 mg) |
Tablet |
II (Paddle) |
75 |
6.0% w/v Polysorbate 20 in 50 mM Phosphate Buffer, pH 6.8 |
900 |
10, 20, 30, 45 and 60 |
2020/04/02 |